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Abstract
Resistance is the result of bacteria evolving new genes in response to the presence of pes‐
ticide and antibiotics. In our society day by day, a number of chemicals, pesticides, and
antibiotics are introducing due to the result of resistance development of bacteria. Pesti‐
cides are added to the environment for the purpose of killing or injuring some form of
life. Pesticide resistance describes the decreased susceptibility of a pest population to a
pesticide that was previously effective at controlling the pest. Bacteria have been used ex‐
tensively for bioremediation purposes. The ability of organisms to bioremediate pesti‐
cides is mainly based on their biodegradation activity. Methomyl and imidacloprid are
widely using throughout the world as a pesticide. Many pesticide degradation genes
present in soil bacteria have been shown to reside on plasmids or genome, a common lo‐
cation for other degradation genes. The excessive use of pesticides and antibiotic leads
and promotes the development of resistance in the bacteria. An increase in the frequency
of antibiotic resistance in bacteria since the 1950s has been observed for all major classes
of antibiotics used to treat a wide variety of diseases. Development of resistance is a ma‐
jor concern for another reason of human and animal health. Antibiotic resistance profiles
of the isolates must be done earlier to the use of antibiotics in both to choose appropriate
antibiotic for treatment and prevention of the disease. Research into newer antibiotics
continues, measures can and should be taken to reverse the practices that promote the de‐
velopment of antibiotic resistance in bacteria.
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1. Introduction
Resistance  is  the  result  of  bacteria  evolving  new  genes  in  response  to  the  presence  of
pesticides and antibiotics, as a result the bacteria will be capable of remain in the surround‐
ings.  A  number  of  xenobiotics  and  antibiotics  are  introducing  due  to  the  result  of  the
resistance development of bacteria. The productive use of any therapeutic agent is conceded
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by the potential development of tolerance or resistance to that compound from the time it
is first applied. These remains very true for the agents are used in the treatment of parasitic
and microbial infections and for the treatment of chronic disorders like cancer and diabetes,
and it apply to conditions caused or suffered by any living organisms, including plants,
insects,  humans,  animals,  fish,  etc.  Many  changes  in  physiological  and  biochemical
mechanisms may be responsible for the incidence of resistance. In the case of antimicrobi‐
al agents and insecticides, the specific complexity of the developments that contributes to
the  emergence  and  spreading  of  resistance  cannot  be  overemphasized,  and  also,  some‐
time  lack  of  basic  information  and knowledge  on  these  issues  is  one  of  the  major  pri‐
mary reasons that there has been very much slight significant achievement in the effective
prevention and control of resistance development in the organisms [1]
2. Pesticides resistance in bacteria
Agriculture is the most essential of the Indian economy. It ensures food security for the biggest
population with shrinking cultivable land resource necessitates use of high yielding variety of
seeds, balanced use of fertilizers, and judicious use of quality pesticides. The indiscriminate
and unplanned use of agrochemicals influences microbial processes that are an essential
component of carbon, nitrogen, and sulfur cycles.
Pesticides are added to the environment for the purpose of killing or injuring the pests.
Pesticides are the chemical substances that kill pests like fungi, insects, worms, nematodes,
etc., which cause damage to field crops. It is almost impossible to control the spreading of
pesticides effect. Even though it is applied in very much small area, it is dissolves in water,
absorbed by soil, and spreads through the air. The contaminated water ultimately reaches
much bigger and new area. These pesticides also frequently trickle into ground water, which
we humans consume, and as a result, these pesticides poison us over a period of time.
However, in addition to these, residual pesticides that remain on the plants are sometimes
consumed by animals and also humans, leading to serious many disorders like cancer and
even sometimes death. The excessive use of pesticides leads to an accumulation of a huge
amount of pesticide residues in the food chain and drinking water environment that further
leads to a substantial health hazard for the current and future generations due to uptake and
accumulation of these toxic compounds [2]. Majority of agrochemicals devoid of mutagenic
activity and induce their effects by genotoxic or non genotoxic modes of action. However, in
some cases, the modes of action are known and they give a clear indication of the likely human
hazards, but in many cases, the data are lacking or incomplete resulting in a more conventional
approach toward human hazard and risk assessment [3].
Pesticides can be classified according to their toxicity, chemical group, environmental persis‐
tence, target organism, or other features. Classes of organic pesticides (consisting of organic
molecules) include organochlorine, organophosphate, organometallic, pyrethroids, and
carbamates among others [4]. The use of explosives, refrigerants, pesticides, solvents, and
many dyes in urban, industrial, and agricultural applications results into the release of
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xenobiotic compounds into the environment, and the problem of such toxic waste disposal has
become enormous due to the proliferation of these xenobiotic compounds. Many xenobiotic
compounds, particularly those used as insecticides, are toxic. Insecticides have been reported
to affect the microbial populations by controlling the survival and reproduction of species.
Biodegradation and bioremediation are identical processes to an extent that both of these are
based on the conversion or metabolism of many chemicals and pesticides by microorganisms.
Here, the difference is that biodegradation is a natural process while bioremediation is a
technology. A successful bioremediation technique requires an efficient bacterial strain that
can degrade largest pollutant to minimum level [5]. Soil microorganisms play a key role in
biodegradation. Soil microorganisms are of great concern for using in biotechnology because
they are able to metabolize and degrade many of pollutants and pesticides. Simultaneously,
on the other hand, microbial degradation can lead to formation of more toxic and persistent
metabolites. Although the soil microbial population are characterized by their adaptability to
the changed environmental condition, fast flexibility and the application of pesticides in long
term as well as in short term can cause significant irreversible changes in their population.
Bioremediation constitutes an attractive alternative to physicochemical methods of remedia‐
tion, as it is less expensive and can selectively achieve complete destruction of organic
pollutants. In bioremediation, microbes that can degrade the pesticides in-situ are used. For a
successful bioremediation technique, an efficient bacterial strain that can degrade largest
pollutant to minimum level is required. In predicting the persistence of synthetic chemicals in
soil, sediment, and natural water, it is necessary to determine the role of endogenous micro‐
organisms in the overall degradation process.
The ability of organisms to bioremediate pesticides is mainly based on their biodegradation
activity. Although bioremediation has been firstly achieved using microorganisms (bacteria
or fungi), other organisms like plants or algae can be used. To eradicate undesirable effects of
pollutants from the environment the strategy of bioremediations are used. However, this
method is not always possible and sometimes it would be appropriate to eliminate pollutants,
although some organisms could restrict or immobilize them. For an instance, the used
organisms can accumulate contaminants and to some extent decrease their presence and their
environmental effect, but they do not completely eliminate them from the environment. Those
organisms able to bioremediate would be called bioremediators. Traditionally, bioremediation
has been achieved by using microorganisms [6].
Pesticide resistance describes the decreased susceptibility of a pest population to a pesticide
that was previously effective at controlling the pest. Pest species develop pesticide resistance
via natural selection; as a result, the highest resistant varieties survive and continuously
transfer their genetic traits to their next generation [7]. Many times, when pesticide degradation
happens, it usually involves more than one microorganism, i.e., each microorganism contrib‐
utes to the process of biodegradation reactions on pesticides. However, there is no evidence,
and an example of mineralization by a single strain has been described. It shows that the
presence of different microorganisms is essential for an adequate and significant biodegrada‐
tion. Reported micro-biodegraders belong to Basidiomycetes or to bacterial classes: gamma-
proteobacteria (Pseudomonas, Aerobacter, Acinetobacter, Moraxella, and Plesiomonas), beta-
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proteobacteria (Burkholderia and Neisseria), alpha-proteobacteria (Sphingomonas),
actinobacteria (Micrococcus), and flavobacteria (Flavobacterium) [6].
Many studies have focused on the employment of bacteria, consortia or on the search for
biotransformation enzymes. Bacteria have been used extensively for bioremediation purposes
due to their fast growth, easy handling, and low cost, making them suitable for bioremediation.
However, some disadvantages are there, such as the pathogenicity of bacteria, disposal of
bacterial biomass, and bioactivation, among others. Bacteria can be found in the environment
everywhere such as soil, water, or even in particles dispersed in air. Unfortunately, only a small
segment of bacteria (<10% from soil) can be cultured in laboratory conditions. Because of this,
a number of studies about pesticide biodegradation mechanisms are less than those about
biodegrader’s isolation and then slight information on biochemical mechanisms or enzymes
is accessible.
Pollutants might undergo biodegradation reactions like cleavage, oxidation, de-chlorination,
reduction by different enzymes. Since biodegradation capability is based on enzymes, which
are promiscuous and have evolved to detoxifying enzymes, the shorter the duplication time
of organism and the more sufficient the organism, the easier to obtain biodegraders. Therefore,
bacteria with replication time around or less than minutes are much admirable to respond to
natural and artificial pollutant-induced evolutionary pressure; this response is involved in the
selection of biotransformation enzymes able to degrade them. These promiscuous enzymes
are present in the organisms; even before the exertion of the evolutionary pressure, the induced
genetic recombination or mutation in the organisms could lead to enzymes with better
biodegradation ability [6].
The carbamates are mainly used in agriculture, as insecticides, fungicides, herbicides, nema‐
tocides, or sprout inhibitors; also, it is used as a potential in public health vector control. In
addition, these carbamates are used as biocides for industrial or other applications and in
household products. As a result, these chemicals are part of the large group of synthetic
pesticides that have been developed, produced, and used on a large scale in the society and
environment. They are derivatives of carbamic acid and like organophosphates; the mecha‐
nism of action of these chemicals is that inhibiting the vital enzyme acetyl cholinesterase is
reversible as compared to organophosphates, which is irreversible. Exposure to cholinesterase
inhibiting agents is considered as a major health problem for the farm workers throughout the
world.
Three classes of carbamate pesticides are generally known. The carbamate herbicides have the
general structure R1NHC(O)OR2, in which R1 and R2 are aromatic and/or aliphatic moieties.
The carbamate ester derivatives, used as insecticides (and nematocides), are usually stable and
have a low vapor pressure and low water solubility. Fungicide carbamate contains a benzi‐
midazole group. Carbamates are metabolized by microorganisms, plants, and animals or
broken down in water and soil. Soil microorganisms have the capacity of metabolizing
(hydrolyzing) carbamates and can easily acclimate themselves to metabolize the different
types of carbamates. However, at the high dose levels of carbamates, their metabolites cause
changes and can significantly affect the microflora, which may be of importance in soil
productivity. Some of the common names of the carbamate insecticide are aldoxycarb,
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allyxycarb, aminocarb, bufencarb, butacarb, carbanolate, carbaryl, carbofuran, aldicarb,
methomyl, oxamyl, thiofanox, thiodicarb, etc.
2.1. Methomyl
Methomyl is widely used throughout the world since it is effective as “contact insecticide” as
well as “systemic insecticide.” The IUPAC name of methomyl is S-methyl N-(methylcarba‐
moyloxy) thioacetimidate. Methomyl belongs to a class of compounds known as oxime
carbamates, and it is widely used for the control of insects and nematode pests by inhibiting
the enzyme acetylcholinesterase, which hydrolyzes the neurotransmitter acetylcholine [8].
Methomyl has been classified as a pesticide of category-I toxicity [9]. Methomyl is a metabolite
of thiodicarb, and acetimidate is a suspected oncogen, which is metabolite in animal tissues
[10]. Methomyl is endocrine disruptor and also potent genotoxic, capable of inducing struc‐
tural and numerical chromosomal aberration in mammalian cells [11]. The World Health
Organization (WHO), Environment Protection Agency (EPA), and European Chemical
Classification (ECC) classify methomyl as a very toxic and a most hazardous pesticide.
Methomyl is highly soluble in water (57.9 g/liter, at 25°C [8]), and since the sorption affinity
of soils for this pollutant is rather low, it can easily cause contamination of both ground and
surface water resources [12].
The study of methomyl-induced alteration in mice hepatic-oxidative status and methomyl-
induced  gonadal  dysfunction,  biochemical  contents,  and  enzyme activities  in  mice  sug‐
gests that chronic exposure to methomyl insecticide has deleterious effect on mouse liver
and also showed effect on reproductive system in mice. Therefore, the application of such
insecticide  for  designed  program  should  be  limited  or  special  care  should  be  taken  to
minimize its hazards [13, 14].
Many pesticide degradation genes present in soil bacteria have been shown to reside on
plasmids, a common location for other degradation genes [15, 16]. Some plasmids are known
as catabolic plasmids because they bear genes encoding for enzymes capable of degradation
and such plasmids have been of great attraction. The organisms containing the catabolic
plasmids have the ability to degrade certain compounds. Many catabolic plasmids have been
found in species of Actinobacter, Flavobacterium, Pseudomonas, Alcaligenes, Klebsiella, Moraxel‐
la, and Arthrobacter [17].
The innovation of microorganisms capable of tolerating or growing in high concentrations of
pesticides provides a potentially interesting possibility for treating hazardous wastes [18].
Some investigations resulting in the identification of microbial isolates, which are apparently
responsible for the accelerated degradation of individual pesticides, is necessary [19]. Many
xenobiotic degradation genes present in soil bacteria have been shown to reside on plasmid,
a common location for other degradation genes [20]. The study of plasmid curing suggests that
the degrading ability for methomyl is encoded in the plasmid for the genus Pseudomonas
aeruginosa [21]. Soil microbial populations, particularly members of Pseudomonas, Bacillus, and
Escherichia coli have evolved the considerable nutritional versatility and are capable of the
degradation of a range of complex, naturally occurring aromatic and aliphatic compounds. An
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interesting feature of these degradative plasmids is that they have been isolated almost
exclusively from the species of the genus Pseudomonas, Bacillus, and E. coli [22].
It is suggested that the detoxification metabolism occurs when a microorganism uses the
pesticide as a carbon and energy source and the process is assisted by resistant microorganisms
[23]. The plasmid-coded biodegradation of methomyl may be due to the broad host range
plasmids and selection pressures on spontaneous mutants due to the presence of xenobiotics,
vertical gene transfer, or horizontal gene transfer, including transposons and broad host range
plasmids and selection pressures on spontaneous mutants due to the presence of xenobiotics
or due to strains that harbor a single plasmid with a role in pesticide biodegradation [24].
The proteomic profiling of E. coli in response to carbamate pesticide–methomyl research work
was conducted by Kulkarni and Kaliwal [25]. The study suggests that the proteomic profiling
is a sensitive tool for environmental stress diagnosis and that the stress proteins could be used
as biomarkers for environmental pollution identification. Thus, biological decontamination
methods are preferable to conventional approaches because, in general, microorganisms
degrade numerous environmental pollutants without producing toxic intermediates [26, 27].
2.2. Imidacloprid
Imidacloprid is the first synthetic neonicotinoid insecticide used against sucking pests, such
as rice hoppers, aphids, thrips, and whiteflies. Imidacloprid has been used widely for foliar
and seed treatment, soil drench, and stem application [28]. Today imidacloprid is used in over
120 countries to treat more than 140 different crops [29]. It is most commonly used on cotton,
rice, cereal, maize, sunflowers, potatoes, and vegetables. The active chemical in imidacloprid
works by interfering with the transmission of stimuli in the insect’s nervous system. Imida‐
cloprid is a neurotoxic insecticide, which belongs to the class of the neonicotinoid pesticides.
Imidacloprid is registered to control insect pests on agricultural and nursery crops, structural
pests, and parasites on companion animals. Imidacloprid is an agonist of the nicotinic
acetylcholine receptor (nAChR) at the neuronal and neuromuscular junctions in insects and
vertebrates. It is structurally and functionally related to nicotine. The toxicity of imidacloprid
is largely due to interference of the neurotransmission in the nicotinic cholinergic nervous
system. Extended activation of the nAChR by imidacloprid causes desensitization and
blocking of the receptor and leads to incoordination, tremors, decreased activity, reduced body
temperature, and death.
The ability of some microorganisms to grow in the presence of pesticides may result in the
compensation of an adverse effect by the increased activity of remaining part of soil commun‐
ity. Bacteria’s are known to become resistant to toxic compound with production of specific
degrading enzymes [30]. Three imidacloprid tolerant strains were isolated and identified
based on morphology, biochemical characters and 16s rDNA identification as E. coli (Fig. 1),
Brevundimonas sp. MJ 15 (Fig. 2), and Bacillus weihenstephanensis (Fig. 3), and they were
evaluated for their toxicity toward imidacloprid using standard methods to determine their
biochemical contents, growth, and enzyme parameters on exposure to the toxicant and
concluded that imidacloprid-induced toxicity and stress in bacterial soil isolates. The knowl‐
edge about intoxication effects and conservation of toxicity mechanisms in organisms will
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enable to choose appropriate model organisms for relevant monitoring of specific environ‐
mental toxicants [31].
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Figure 1. Phylogenetic tree of E. coli.
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Figure 2. Phylogenetic tree of Brevundimonas sp. MJ 15.
Genes responsible for pesticide degradation in microorganism have been found to be located
on plasmids, transposons, and chromosomes. Some microbial strains possess genetic deter‐
minants that confer resistance. In bacteria, these determinants are often found on plasmids,
which have facilitated their study at the molecular level [32]. The involvements of plasmids in
degradation of organic xenobiotics were first reported 20 years ago, and the list is increasing
continuously till today [33]. Such type of plasmids have mostly found in xenobiotic degrading
bacteria, after selective isolation of the strain by many methods. Also, direct exogenous
plasmid isolation has yielded several novel catabolic plasmids more recently. The involvement
of plasmids in degradation of pesticides in reported in several studies. Plasmid encode the
genes were found responsible for degradation of anthracene, fenitrothion, carbofuran,
dimethoate, phenanthrene, and dichlorophenoxyacetic acid by Pseudomonas sp., Burkholderia
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 sp., Sphingomonas sp., Bacillus licheniformis, Flavobacterium sp., and Alcaligenes paradoxus,
respectively [34, 35].
3. Antibiotic resistance in bacteria
Antibiotic use promotes the development of antibiotic-resistant bacteria. Every time a person
takes antibiotics, sensitive bacteria are killed, but resistant bacteria may be left to grow and
multiply. Bacteria can be described as being susceptible to, tolerant of, or resistant to specific
antibiotics. When an antibiotic attacks a group of bacteria, those cells that are susceptible will
die.
The primary cause of increase in drug-resistant bacteria is mainly because of repeated and
improper uses of antibiotics. The keen use of antibiotics is the key to controlling the spread of
resistance bacteria. For example, antibiotics should be used for the treatment of bacterial
infections, but many times, they are given for the viral infections such as common cold, most
sore throats, and the flu, for which they have not prepared. Extensive and widespread use of
antibiotics promotes the spread of antibiotic resistance. Antibiotic resistance occurs when
bacteria changes in some way that decreases or eliminates the effectiveness of drugs or other
Figure 3. Phylogenetic tree of Bacillus weihenstephanensis.
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agents designed to cure or prevent infections. As a result, the bacteria survive and continue to
multiply causing more harm to the host. This can be performed by bacteria by several
mechanisms. Some bacteria develop the ability to neutralize the antibiotic before it can do
harm, others can rapidly impel the antibiotic out, and still others can change the antibiotic
attack site so it cannot affect the normal function of the bacteria.
An increase in the frequency of antibiotic resistance in bacteria since the 1950s has been
observed for all major classes of antibiotics used to treat a wide variety of diseases. There may
be many reasons such as resistance is the result of bacteria evolving new genes in response to
the presence of antibiotics, or the antibiotic-resistant bacteria selected for in the environment
by possessing antibiotic resistance genes and also several factors involved in antibiotic
resistance will show that resistance is a designed feature of preexisting genes enabling bacteria
to compete with the antibiotic producers in their environment.
3.1. Antibiotic resistance in humans
The development of resistance in bacteria is a major concern for another reason of human
health. Historically, infectious diseases have killed billions of people and have the reason for
most devastating chapters in the history of humankind. Scientists have been so successful in
the earlier century in preventing and curing infectious diseases that only a few years ago, it
was thought that modern science had at last enabled us to “close the book on infectious
diseases.” Bacteria that have become resistant to several antibiotics, said to be multidrug
resistant, are often called super bugs by the media. An important mechanism by which bacteria
become resistant is by obtaining one or more specific resistance genes from other bacteria. This
type of resistance can be acquired by the transfer of a plasmid, already existing in the bacterium
gene pool that carries a gene for an enzyme which either destroys or inactivates the antimi‐
crobial substance.
Staphylococcus aureus is a major cause of hospital-acquired infections, causing high morbidity
and mortality throughout the world. Vancomycin has been the drug of choice for 30 years for
the treatment of methicillin-resistant S. aureus (MRSA). Over the last decade, methicillin-
resistant S. aureus (MRSA) strains have become endemic in hospitals worldwide. In addition,
it is now incipient community pathogen in many geographical regions. The emergence of high
levels of penicillin resistance followed by development and spread of strains resistant to the
semisynthetic penicillins (methicillin, nafcillin, and oxacillin), macrolides, tetracyclins, and
amino glycosides has made therapy of staphylococcal disease a global challenge. Now a day’s
resistance to semisynthetic penicillin’s had spread throughout the world, compromising the
use of these drugs for empiric therapy for staphylococcal infections in a number of regions.
This had led to increased reliance on vancomycin for the treatment of documented MRSA
infections. As a consequence, selective pressure was established that eventually lead to the
emergence of strains of S. aureus and other species of staphylococci with decreased suscepti‐
bility to vancomycin and other glycopeptides (Fig. 4).
Vancomycin is the only effective agent against some pathogens, and even in recent years, it
has been lost some of its effectiveness. This problem has many causes, including the improper
and misuse of antibiotics and the result of transfer of resistance genes from one bacterium to
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another. This might be possible because many bacteria have an integral natural resistance to
a number of antibiotics, and the genes that provide this resistance can be passed on to other
bacteria by a variety of means. Multidrug-resistant S. aureus (MDRS) is a much more serious
threat, particularly to hospitalized patients in globally, and it represents a challenge for public
health, as community-acquired infections seem to be on the increase in adults and children.
S. aureus colonization has been shown to be a major risk factor for community-acquired and
nosocomial infections. In epidemiological study, Unakal and Kaliwal [36] reported the
multidrug resistance and vancomycin resistance S. aureus isolated from Health Care Centres
in India for the first time and detected Van A gene in 4 strains, Van B gene in one strain from
the 14 VRSA strains procured from the clinical samples pus, infected blood, and cerebrum
spinal fluid.
The first report of the S. aureus with reduced susceptibility to vancomycin was from Japan [37].
This report was quickly followed by similar ones from other countries, including the United
States [38] and Belgium [39]. The extensive longitudinal study of the current situation of
vancomycin resistance has reported the first incidence of VRSA emergence from northern part
of India [40]. The first clinical infection with vancomycin-resistant S. aureus was reported from
Michigan, with second case in Pennsylvania. Further, the second confirmed VRSA from
Pennsylvania was reported, which represents the VRSA isolate from patient in the United
States. The emergence of decreased vancomycin susceptibility in MRSA strains presents a
significant clinical problem with few therapeutic options. The rapid evolution of antibiotic
resistance is of considerable concern. Considering high prevalence of MRSA and increased use
of vancomycin, the development of vancomycin resistance (VRSA) in clinical strains seems
Figure 4. Evolution of drug resistance in Staphylococcus aureus.
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likely to occur. In 1996, the documented infection caused by S. aureus with reduced suscepti‐
bility to vancomycin (vancomycin-intermediate S. aureus [VISA]) was reported in Japan [37].
Thereafter, about 20 cases of VISA infections have been reported in several countries, including
Korea [41].
Vancomycin is a glycopeptide antibiotic, and glycopeptide resistance has emerged in S.
aureus with the interspecies transfer of resistant gene from nonpathogenic Enterococcus faecalis
in vitro [42]. Moreover, cellular modification due to prolonged use of vancomycin results in an
increased extracellular material, which cause thickening of cell wall [43, 44].
3.2. Antibiotic resistance in bovines
Bovine mastitis is a common disease entity of dairy cows, accompanied by physical, chemical,
pathological, and bacteriological changes in milk and glandular tissue [45]. It is a harmful
disease affecting the dairy industry worldwide and is a matter of great concern for leading
milk-producing countries like India because of the losses incurred due to high morbidity,
discarded milk, treatment costs, and reduced milk production, thus drawing in more attention
toward its treatment and control [46]. Mastitis is produced by a variety of pathogenic micro‐
organisms. The majority of cases in bovines are infectious, and it has been estimated that up
to 200 microbial species are potential causative agents [47].
The antibiotic efficacy of tetracycline, cefixime, ofloxacin, amoxicillin, and ampicillin was
investigated in S. aureus, E. coli, and B. subtilis-induced mastitis in mice by Chinchali [48], and
the results were evidenced by the bacterial count and inflammatory enzyme activities of
mammary gland tissue against the induced bacterial pathogens in comparison with control
group. In the results, there was an orderly decrease in the bacterial counts of S. aureus, E. coli,
and B. subtilis, which showed susceptibility for the antibiotics used in the study and indicated
their effectiveness of bactericidal activity and their efficacy level against the induced inflam‐
matory reaction. This study demonstrates the effectiveness of the antibiotic in the treatment
of the disease. However, continued use and overuse of the antibiotics without an in vitro study
will lead to the antibiotic resistance strains.
The usage of antibiotics in the bovine mastitis correlates with the emergence and maintenance
of antibiotic-resistant traits within pathogenic strains [49]. These traits are coded by particular
genes that may be carried on the bacterial genome or plasmids [50]; hence, these are easily
transferred among isolates. The prevalence of antibiotic resistance usually varies between
isolates from the different sampled area, environment, and even between isolates from
different herds on the same farm or environment [51].
The evolution of antibiotic resistance in S. aureus strains is a serious cause of concern in dairy
animals [52]. Antibiotic-resistant S. aureus isolates pose a severe challenge to both in veterinary
and health professions and in dairy cattle producers because they have a serious negative
impact on the therapy management. S. aureus has been and become the main issue of studies
on antibiotic resistance because of its importance for all forms of mastitis in dairy cows [53].
Multiple antibiotic-resistant S. aureus strains have been isolated and screened from milk
obtained from cattle, beef, and human samples from the various part of the world.
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Antimicrobials have been used frequently as a conventional measure to prevention and control
diseases in dairy farming. Especially in mastitis control programs, more and more antibiotics
were applied even without any clinical symptoms in dairy cattle herds. However, long-term
in-feed use of antibiotics on dairy farms has led to the alarming increase of antibiotic-resistant
bacteria, which has become a public health issue worldwide, e.g., methicillin-resistant S.
aureus (MRSA) from raw milk and environmental samples constitutes a great threat to food
safety. In order to better understand the potential of dairy cattle as a reservoir for antibiotic-
resistant bacteria, it is important to investigate the prevalence of antimicrobial resistance
among bacteria isolated from raw milk [54].
References [55–59] reported many bovine mastitic bacteria and reported the isolated bacteria
were resistant to many antibiotics. Sadashiv [60] isolated a total of 878 strains of bacteria from
bovine mastitis (Table 1), which showed multidrug resistance to the antibiotics such as
amikacin, amoxyclav, ampicillin, methicillin, oxacillin, penicillin G, cefaclor, cefixime,
cefpodoxime, ceftriaxone, ciprofloxacin, norfloxacin, ofloxacin, gentamicin, azithromycin,
erythromycin, streptomycin, tetracycline, and chloramphenicol. Further, the strains were
identified by 16s rDNA method. Due to wide sampling area, the identified strains were
subjected to random amplified polymorphic DNA (RAPD) polymorphism analysis and found
huge diversity among the strains, demonstrating the migration of the antibiotic resistance
strains (Fig. 5). The study concluded that the examination of the antibiotic resistance profiles
of the isolates must be done earlier to the use of antibiotics in both to choose appropriate
antibiotic for treatment and prevention of the disease.
Sl. no Bacteria Isolates Percentage (%)
1 Staphylococcus aureus 210 23.91
2 Coagulase-negative Staphylococcus 165 18.79
3 Bacillus spp. 221 25.17
5 Escherichia coli 97 11.04
4 Pseudomonas spp. 72 8.20
7 Aerococcus spp. 34 3.87
6 Cronobacter spp. 23 2.61
8 Others 56 6.37
Total 878 100
Table 1. Prevalence of different bacterial isolates from the bovine mastitis milk.
It is possible that mastitogenic bacteria can lose the sensitivity to antibiotics over the time or
even acquire sometimes this feature [61]. Important reasons for the failure of treatment of
mastitis are the indiscriminate use of antibiotics without in vitro sensitivity of causal organisms.
It is necessary to monitor mastitis pathogens to assess any changes in their antibiotic resistance
patterns. Careful use of antibiotics can avoid the increase and dissemination in antimicrobial
resistance arising from the use of antimicrobial drugs in animals.
Insecticides Resistance
Some pharmaceutical companies have expanded their R&D efforts due to in response to the
increased number of bacteria that have developed resistance to the one or more number of
antibiotics. New drugs are being developed which interfere with the resistant cells and the
method of new defence against certain antibiotics. For example, bacteria resistant to penicillin
produce the enzyme penicillinase, which breaks up the penicillin before it can perform its
work. Presently, a penicillinase inhibitor is available that is taken in tandem with the penicillin,
therefore by preventing the penicillinase from destroying the penicillin and by allowing the
antibiotic to perform its work [62].
The increased use, and sometimes misuse, of antibiotic drugs has resulted in bacterial
resistance to a large and growing number of these drugs. However, much more research into
newer and newer antibiotics continues, and measures can and must be taken to reverse the
practices that usually promote the development of antibiotic resistance in bacteria.
4. Conclusion
Presently, the development of resistance in all microorganisms is one of the major concerns
and challenges throughout the world. The development of resistance can be achieved by the
microorganisms by many ways. The smart, keen, and controlled use of pesticides, chemicals,
and antibiotics will be much helpful in controlling the development of resistance. However,
screening newer microbes and using newer recombinant technology on the screened microbes
will help us reduce the resistance to xenobiotics compounds.
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